201 related articles for article (PubMed ID: 31241292)
1. Epidemiology of rare diseases detected by newborn screening in the Czech Republic.
David J; Chrastina P; Pešková K; Kožich V; Friedecký D; Adam T; Hlídková E; Vinohradská H; Novotná D; Hedelová M; Al Taji E; Holubová A; Skalická V; Macek M; Gaillyová R; Votava F
Cent Eur J Public Health; 2019 Jun; 27(2):153-159. PubMed ID: 31241292
[TBL] [Abstract][Full Text] [Related]
2. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan.
Niu DM; Chien YH; Chiang CC; Ho HC; Hwu WL; Kao SM; Chiang SH; Kao CH; Liu TT; Chiang H; Hsiao KJ
J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S295-305. PubMed ID: 20567911
[TBL] [Abstract][Full Text] [Related]
3. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region.
Martín-Rivada Á; Palomino Pérez L; Ruiz-Sala P; Navarrete R; Cambra Conejero A; Quijada Fraile P; Moráis López A; Belanger-Quintana A; Martín-Hernández E; Bellusci M; Cañedo Villaroya E; Chumillas Calzada S; García Silva MT; Bergua Martínez A; Stanescu S; Martínez-Pardo Casanova M; Ruano MLF; Ugarte M; Pérez B; Pedrón-Giner C
JIMD Rep; 2022 Mar; 63(2):146-161. PubMed ID: 35281663
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.
Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A
Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418
[TBL] [Abstract][Full Text] [Related]
7. Neonatal screening in the Czech Republic: increased prevalence of selected diseases in low birthweight neonates.
David J; Chrastina P; Vinohradska H; Al Taji E; Holubova A; Hlidkova E; Kozich V; Votava F
Eur J Pediatr; 2018 Nov; 177(11):1697-1704. PubMed ID: 30136145
[TBL] [Abstract][Full Text] [Related]
8. The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa Dehydrogenase Deficiency (Lchadd).
Bessey A; Chilcott J; Pandor A; Paisley S
Value Health; 2014 Nov; 17(7):A531. PubMed ID: 27201686
[No Abstract] [Full Text] [Related]
9. Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study.
Rücklová K; Hrubá E; Pavlíková M; Hanák P; Farolfi M; Chrastina P; Vlášková H; Kousal B; Smolka V; Foltenová H; Adam T; Friedecký D; Ješina P; Zeman J; Kožich V; Honzík T
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578803
[TBL] [Abstract][Full Text] [Related]
10. [Newborn screening in France: news and perspectives].
Gernez E; Roland E; Dhaenens CM; Renom G; Mention K
Ann Biol Clin (Paris); 2024 Apr; 82(1):24-31. PubMed ID: 38638016
[TBL] [Abstract][Full Text] [Related]
11. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
[TBL] [Abstract][Full Text] [Related]
12. [The advisory report 'Neonatal screening' from the Health Council of The Netherlands].
Bolhuis PA; Page-Christiaens GC
Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2857-60. PubMed ID: 16398167
[TBL] [Abstract][Full Text] [Related]
13. Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.
Autti-Rämö I; Mäkelä M; Sintonen H; Koskinen H; Laajalahti L; Halila R; Kääriäinen H; Lapatto R; Näntö-Salonen K; Pulkki K; Renlund M; Salo M; Tyni T
Acta Paediatr; 2005 Aug; 94(8):1126-36. PubMed ID: 16188860
[TBL] [Abstract][Full Text] [Related]
14. Expanded newborn screening in Greece: 30 months of experience.
Loukas YL; Soumelas GS; Dotsikas Y; Georgiou V; Molou E; Thodi G; Boutsini M; Biti S; Papadopoulos K
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S341-8. PubMed ID: 20721692
[TBL] [Abstract][Full Text] [Related]
15. Incidence of newborn screening disorders among 56632 infants in Central Saudi Arabia. A 6-year study.
Mohamed S; Elsheikh W; Al-Aqeel AI; Alhashem AM; Alodaib A; Alahaideb L; Almashary M; Alharbi F; AlMalawi H; Ammari A; Almohaimeed S
Saudi Med J; 2020 Jul; 41(7):703-708. PubMed ID: 32601637
[TBL] [Abstract][Full Text] [Related]
16. Tandem mass spectrometry screening for very long-chain acyl-CoA dehydrogenase deficiency: the value of second-tier enzyme testing.
Spiekerkoetter U; Haussmann U; Mueller M; ter Veld F; Stehn M; Santer R; Lukacs Z
J Pediatr; 2010 Oct; 157(4):668-73. PubMed ID: 20547398
[TBL] [Abstract][Full Text] [Related]
17. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
[TBL] [Abstract][Full Text] [Related]
18. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.
Hamers FF; Rumeau-Pichon C
BMC Pediatr; 2012 Jun; 12():60. PubMed ID: 22681855
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
